Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
2
×
clinical trials
fda
life sciences
national blog main
480 biomedical
arsenal medical
biotech ipos
bob langer
chronic rhinosinusitis
covid-19
deals
drug delivery
dyne therapeutics
genzyme
george whitesides
inflammation
investing
ipo
keros therapeutics
lyra therapeutics
medical device
metacrine
mometasone furorate
myotonic dystrophy type 1
nonalcoholic steatohepatitis
north bridge venture partners
oric pharmaceuticals
perceptive advisors
polaris venture partners
rare disease drugs
rare diseases
renaissance capital
salk institute
san diego blog main
san diego top stories
startups
What
company
2
×
developing
ipo
million
raised
therapeutics
2
×
biotech
brings
debut
disorders
drug
dyne
dyne’s
genetic
late
lyra
markets
medicines
muscle
muscular
new
nose
noses
persistently
preclinical
public
raises
rare
runny
stage
tech
tests
topped
treat
upsized
way
Language
unset
Current search:
therapeutics
×
company
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
